Novel Embossed Negative Pressure Wound Therapy Dressing Demonstrates Equal Efficacy to Traditional Foam and Gauze Devices in Independently Monitored GLP Comparison Study Post author:appliedtissue Post published:January 4, 2021 Post category:Uncategorized Applied Tissue Technologies (ATT), an advanced wound care company, announced the publication of a peer reviewed study in Plastic and Reconstructive Surgery Journal®, “Study Comparing Platform Wound Dressing (PWD® ), a Negative-Pressure Device without a Filler, with Three Conventional Negative-Pressure Wound Therapy Systems in the Treatment of Excisional and Incisional Wounds”. Click here for the full article You Might Also Like Applied Tissue Technologies Announces additional Patent for next generation negative pressure wound therapy device April 11, 2014 Platform Wound Device/ New Breakthrough in NPWT to be presented at SAWC Poster Session April 2017. Embossed device eliminates the need for foam or gauze wound filler when treating wounds with Negative Pressure Wound Therapy January 12, 2017 Xpansion is now exclusively distributed in the western hemisphere by January 8, 2014
Applied Tissue Technologies Announces additional Patent for next generation negative pressure wound therapy device April 11, 2014
Platform Wound Device/ New Breakthrough in NPWT to be presented at SAWC Poster Session April 2017. Embossed device eliminates the need for foam or gauze wound filler when treating wounds with Negative Pressure Wound Therapy January 12, 2017